Pfizer and BioNTech’s supplemental Biologics License Application (sBLA) has been approved by the US Food and Drug ...

Eli Lilly has shared positive top-line results from a late-stage study of its investigational oral glucagon-like peptide-1 ...

Eli Lilly has announced that Anne White, executive vice president and president of Lilly Neuroscience, is set to retire after more than 30 years with the company. Anne will remain in her role, and as ...

The UK government has published its 10-Year Health Plan for England, which will see millions of patients being treated and ...

Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...

When she’s not taking on challengers on the pickleball court, you can find Heather Lavigne leading Medscape Education’s ...

Ianalumab has a dual mechanism of action, B-cell depletion and BAFF-R inhibition, and is being investigated across various B ...

The alliance, originally announced in November 2023, combines Almirall’s dermatological capabilities with Absci’s Integrated ...

The US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ Ajovy (fremanezumab-vfrm) to prevent episodic migraine in paediatric patients. The drug, which is already approved in the ...

Boehringer Ingelheim’s Hernexeos (zongertinib) has been granted accelerated approval by the US Food and Drug Administration ...

The global clinical and commercial partnerships agreed between IQVIA and Veeva Systems include the complete resolution of all pending legal disputes. The long-term agreement enables customers to use ...

But here’s a question: have you, or a friend, or a family member, felt overwhelmed trying to sift through vast amounts of ...